Jade Biosciences, Inc. Common Stock logo

Jade Biosciences, Inc. Common Stock

JBIO • NASDAQ

Jade Biosciences, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Tom Frohlich, with a market cap of $660.3M.

CEOTom Frohlich
Market Cap$660.3M
PHARMACEUTICAL PREPARATIONS
Websitejadebiosciences.com

Next Earnings

Upcoming earnings announcement for Jade Biosciences, Inc. Common Stock

Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.49

Earnings History

Past 4 earnings reports for Jade Biosciences, Inc. Common Stock

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Mar 6, 2026Q4 2025
-$0.11Est: -$0.46
+76.1%
-
—SEC10-K
Nov 13, 2025Q3 2025
-$0.48Est: -$0.63
+23.8%
-
—SEC10-Q
Aug 13, 2025Q2 2025
-$0.86Est: -$0.43
-100.0%
-
—SEC10-Q
May 14, 2025Q1 2025
-$12.10
—
-
——
View all filings on SEC EDGAR

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Jade Biosciences, Inc. Common Stock (JBIO) Q1 2026 Earnings - Capbase